Response to vigabatrin in relation to seizure type

R. Michelucci, C. A. Tassinari

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to evaluate the efficacy of vigabatrin in relation to the seizure type. A review of the literature concerning the efficacy of vigabatrin in clinical trials was performed. To date, vigabatrin has been used in a small number of patients with generalized seizures: in this group no significant effect was noted. Vigabatrin was also given to a large number of patients with complex partial seizures: in this group vigabatrin produced a greater than 50% decrease in seizure frequency in almost 50% of patients included. This review provides evidence that vigabatrin is effective in the treatment of complex partial seizures: patients with only one seizure type, low seizure frequency and unifocal EEG abnormalities are particularly expected to respond. This implies that patients with complex partial seizures do not constitute an homogeneous group and that various parameters should be considered in the evaluation of the response to treatment.

Original languageEnglish
JournalBritish Journal of Clinical Pharmacology
Volume27
Issue numberSUPPL. 1
Publication statusPublished - 1989

Fingerprint

Vigabatrin
Seizures
Electroencephalography
Clinical Trials

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Response to vigabatrin in relation to seizure type. / Michelucci, R.; Tassinari, C. A.

In: British Journal of Clinical Pharmacology, Vol. 27, No. SUPPL. 1, 1989.

Research output: Contribution to journalArticle

@article{a7685f53461046aa941023dfd0ad5daf,
title = "Response to vigabatrin in relation to seizure type",
abstract = "The purpose of this study was to evaluate the efficacy of vigabatrin in relation to the seizure type. A review of the literature concerning the efficacy of vigabatrin in clinical trials was performed. To date, vigabatrin has been used in a small number of patients with generalized seizures: in this group no significant effect was noted. Vigabatrin was also given to a large number of patients with complex partial seizures: in this group vigabatrin produced a greater than 50{\%} decrease in seizure frequency in almost 50{\%} of patients included. This review provides evidence that vigabatrin is effective in the treatment of complex partial seizures: patients with only one seizure type, low seizure frequency and unifocal EEG abnormalities are particularly expected to respond. This implies that patients with complex partial seizures do not constitute an homogeneous group and that various parameters should be considered in the evaluation of the response to treatment.",
author = "R. Michelucci and Tassinari, {C. A.}",
year = "1989",
language = "English",
volume = "27",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Response to vigabatrin in relation to seizure type

AU - Michelucci, R.

AU - Tassinari, C. A.

PY - 1989

Y1 - 1989

N2 - The purpose of this study was to evaluate the efficacy of vigabatrin in relation to the seizure type. A review of the literature concerning the efficacy of vigabatrin in clinical trials was performed. To date, vigabatrin has been used in a small number of patients with generalized seizures: in this group no significant effect was noted. Vigabatrin was also given to a large number of patients with complex partial seizures: in this group vigabatrin produced a greater than 50% decrease in seizure frequency in almost 50% of patients included. This review provides evidence that vigabatrin is effective in the treatment of complex partial seizures: patients with only one seizure type, low seizure frequency and unifocal EEG abnormalities are particularly expected to respond. This implies that patients with complex partial seizures do not constitute an homogeneous group and that various parameters should be considered in the evaluation of the response to treatment.

AB - The purpose of this study was to evaluate the efficacy of vigabatrin in relation to the seizure type. A review of the literature concerning the efficacy of vigabatrin in clinical trials was performed. To date, vigabatrin has been used in a small number of patients with generalized seizures: in this group no significant effect was noted. Vigabatrin was also given to a large number of patients with complex partial seizures: in this group vigabatrin produced a greater than 50% decrease in seizure frequency in almost 50% of patients included. This review provides evidence that vigabatrin is effective in the treatment of complex partial seizures: patients with only one seizure type, low seizure frequency and unifocal EEG abnormalities are particularly expected to respond. This implies that patients with complex partial seizures do not constitute an homogeneous group and that various parameters should be considered in the evaluation of the response to treatment.

UR - http://www.scopus.com/inward/record.url?scp=0024356458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024356458&partnerID=8YFLogxK

M3 - Article

C2 - 2667603

AN - SCOPUS:0024356458

VL - 27

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - SUPPL. 1

ER -